206 related articles for article (PubMed ID: 4617716)
21. Application of the mouse foot-pad technique in immunologically normal mice in support of clinical drug trials, and a review of earlier clinical drug trials in lepromatous leprosy.
Levy L
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):823-9. PubMed ID: 3325574
[No Abstract] [Full Text] [Related]
22. Kinetic testing of drugs against Mycobacterium leprae in mice. Activity of cephaloridine, rifampin, streptovaricin, vadrine, and viomycin.
Shepard CC; Walker LL; Van Landingham M; Redus MA
Am J Trop Med Hyg; 1971 Jul; 20(4):616-20. PubMed ID: 4398128
[No Abstract] [Full Text] [Related]
23. Are all nonsolid Mycobacterium leprae dead? Does a negative finding in the mouse foot pad indicate that there is actually no growth of M. leprae in the animals?
Chang YT
Int J Lepr Other Mycobact Dis; 1977; 45(3):235-40. PubMed ID: 336555
[TBL] [Abstract][Full Text] [Related]
24. Multiplication of Mycobacterium leprae in the nude mouse, and some applications of nude mice to experimental leprosy.
McDermott-Lancaster RD; Ito T; Kohsaka K; Guelpa-Lauras CC; Grosset JH
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):889-95. PubMed ID: 3325583
[TBL] [Abstract][Full Text] [Related]
25. Assessment of viability by normal mouse foot-pad and bacillary ATP bioluminescence assay in multibacillary cases treated with an MDT regimen using conventional as well as newer drugs like minocycline and ofloxacin.
Gupta UD; Katoch K; Singh HB; Natrajan M; Sharma VD; Katoch VM
Indian J Lepr; 2000; 72(4):437-42. PubMed ID: 11212477
[TBL] [Abstract][Full Text] [Related]
26. Minimal bactericidal dietary concentration of minocycline for Mycobacterium leprae-infected mice is very low and similar to its minimal inhibitory dietary concentration.
Gelbert RH; Siu P; Tsang M; Murray LP
Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):276-7. PubMed ID: 1522371
[No Abstract] [Full Text] [Related]
27. Activity of two doses of rifampin against Mycobacterium leprae.
Husser JA; Traore I; Daumerie D
Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):359-64. PubMed ID: 7963907
[TBL] [Abstract][Full Text] [Related]
28. The rate of bactericidal action of rifampin on Mycobacterium leprae in the mouse footpad.
Holmes IB; Hilson GR
Proc Soc Exp Biol Med; 1974 Apr; 145(4):1395-400. PubMed ID: 4597278
[No Abstract] [Full Text] [Related]
29. In vivo susceptibility of Mycobacterium leprae to sitafloxacin (DU-6859a), either singly or in combination with rifampicin analogues.
Dhople AM; Namba K
Int J Antimicrob Agents; 2003 Mar; 21(3):251-5. PubMed ID: 12636987
[TBL] [Abstract][Full Text] [Related]
30. Antimycobacterial activities of two newer ansamycins, R-76-1 and DL 473.
Ji BH; Chen JK; Lu XZ; Wang SY; Ni GX; Hou YH; Zhou DH; Tang QK
Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):563-77. PubMed ID: 3546547
[TBL] [Abstract][Full Text] [Related]
31. Intermittent rifampicin therapy in lepromatous leprosy.
Girdhar BK; Sreevatsa ; Desikan KV
Lepr India; 1980 Jan; 52(1):89-96. PubMed ID: 6991816
[TBL] [Abstract][Full Text] [Related]
32. [Inadequate rifampicin treatment in multibacillary leprosy and the incubation time of relapse].
Pattyn SR; Husser JA; Baquillon G; Grillone S; Van Loo G; Bourland J
Acta Leprol; 1986; 4(3):301-2. PubMed ID: 3551469
[No Abstract] [Full Text] [Related]
33. Rifampicin resistant leprosy: a review and a research proposal of a pilot study.
Ji B
Lepr Rev; 2002 Mar; 73(1):2-8. PubMed ID: 11969122
[No Abstract] [Full Text] [Related]
34. Primary dapsone resistance in leprosy.
Vaishnavi C; Ganguly NK; Kumar B; Kaur S; Chakravarti RN
Indian J Lepr; 1985; 57(3):507-13. PubMed ID: 3913705
[TBL] [Abstract][Full Text] [Related]
35. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
[TBL] [Abstract][Full Text] [Related]
36. The contemporary relevance of the mouse foot pad model for cultivating M. leprae.
Katoch VM
Lepr Rev; 2009 Jun; 80(2):120-3. PubMed ID: 19743615
[No Abstract] [Full Text] [Related]
37. A comparison of the bactericidal activity of a series of rifampicins against Mycobacterium leprae.
Pattyn SR
Arzneimittelforschung; 1982; 32(1):15-7. PubMed ID: 7037013
[TBL] [Abstract][Full Text] [Related]
38. [Effect of the suppression of the popliteal ganglion in the reproduction of Mycobacterium leprae in the foot-pad of mice. Preliminary report].
Suárez Moreno O; Rodríguez Silveira J
Rev Cubana Med Trop; 1987; 39(3):17-22. PubMed ID: 3327105
[No Abstract] [Full Text] [Related]
39. Activity of phenazine analogs against Mycobacterium leprae infections in mice.
Van Landingham RM; Walker LL; O'Sullivan JF; Shinnick TM
Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):406-14. PubMed ID: 8228439
[TBL] [Abstract][Full Text] [Related]
40. The activity of several newer antimicrobials against logarithmically multiplying M. leprae in mice.
Burgos J; de la Cruz E; Paredes R; Andaya CR; Gelber RH
Lepr Rev; 2011 Sep; 82(3):253-8. PubMed ID: 22125933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
